AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Sulfadimidine
10 registrations across 3 African markets— 7 active
Markets with Sulfadimidine
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| SULFAKEL SOLUTION 33% | 🇬🇭Ghana | KETA LABORATORIA N.V. | expired | Sept 2026 |
| SULFAKEL SOLUTION 33% | 🇬🇭Ghana | KETA LABORATORIA N.V. | active | Sept 2026 |
| SULPHADIM* | 🇿🇦South Africa | BE-TABS PHARMACEUTICALS (PTY) LTD | suspended | Jun 2025 |
| SULPHADIMIDINE 0,5 g TABLETS - LENNON | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Mar 2022 |
| GENDIMIDINE | 🇿🇦South Africa | Alliance Pharma (Pty) Ltd | active | Jan 1900 |
| Injectal Injection | 🇹🇿Tanzania | PHARMA SWEDE - EGYPT | active | — |
| Ashulpha 5 Bolus Bolus | 🇹🇿Tanzania | Ashish Life Science Pvt Limited | active | — |
| S Dime Bolus | 🇹🇿Tanzania | Cosmos Limited | active | — |
| Basulfa 33.3% Solution | 🇹🇿Tanzania | BAJUTA INTERNATIONAL (T) LTD | active | — |
| Basulfa 33.3% Injection | 🇹🇿Tanzania | BAJUTA INTERNATIONAL (T) LTD | active | — |
Sulfadimidine in Africa — Regulatory Overview
Sulfadimidine is registered across 3 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, South Africa, Ghana. AfricaRegulatory refreshes this data daily from official government sources.
Of the 10 registrations, 7 (70%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.